Opinions regarding the diagnosis and management of venous thromboembolic disease. ACCP Consensus Committee on Pulmonary Embolism.
D000933:Antifibrinolytic Agents / Q000097:blood; D004452:Echocardiography; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010100:Oxygen / Q000097:blood; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D015912:Thrombolytic Therapy; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D016306:Vena Cava Filters; D014692:Ventilation-Perfusion Ratio; D016278:Ventricular Function, Right
D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; C036309:fibrin fragment D; D006493:Heparin; D010100:Oxygen